Japanese Government Panel OK’s World’s First Clinical Research Using iPS Cells

logo-japan-timesA government panel Wednesday approved the world’s first clinical research using human induced pluripotent stem (iPS) cells, which can grow into any type of human body tissue, officials said.

The governmental scientific research institute Riken and the Foundation for Biomedical Research and Innovation won the approval from the panel at the health ministry for their clinical research plan to use iPS cells for retinal regeneration.

The research may start this year after official approval by the minister of health, labor and welfare.

The clinical research comes after Kyoto University professor Shinya Yamanaka co-won the 2012 Nobel Prize in physiology or medicine for his development of iPS cells, which may be used for regenerative medicine and drug development.

Masayo Takahashi, an ophthalmologist who heads Riken’s research team on retinal regeneration at the Riken Center for Development Biology, will serve as head of the clinical study at the foundation’s hospital in Kobe.

The full article is located at Japan Times

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s